COVID-19 Rebound
Should We Be Concerned About Viral Rebound With Antiviral Agents?

Released: December 30, 2022

Expiration: December 29, 2023

Fernando Carnavali
Fernando Carnavali, MD
Rasika Karnik
Rasika Karnik, MS, MD
Renslow Sherer
Renslow Sherer, MD
Joseph Torrisi
Joseph Torrisi, PharmD, BCIDP

Activity

Progress
1
Course Completed

Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss COVID-19 rebound, including:

  • Prevalence of COVID-19 rebound
  • COVID-19 rebound and antiviral use
  • Management of COVID-19 rebound